1. Home
  2. SIBN vs IOVA Comparison

SIBN vs IOVA Comparison

Compare SIBN & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$15.40

Market Cap

886.9M

Sector

Health Care

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.60

Market Cap

881.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIBN
IOVA
Founded
2008
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
886.9M
881.3M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SIBN
IOVA
Price
$15.40
$2.60
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
$25.00
$10.45
AVG Volume (30 Days)
535.0K
12.3M
Earning Date
02-23-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,578,000.00
$250,425,000.00
Revenue This Year
$21.95
$60.71
Revenue Next Year
$15.02
$59.35
P/E Ratio
N/A
N/A
Revenue Growth
23.27
175.62
52 Week Low
$12.50
$1.64
52 Week High
$21.89
$6.09

Technical Indicators

Market Signals
Indicator
SIBN
IOVA
Relative Strength Index (RSI) 25.63 51.09
Support Level $15.06 $2.25
Resistance Level $16.86 $2.77
Average True Range (ATR) 0.53 0.21
MACD -0.09 -0.01
Stochastic Oscillator 15.73 43.59

Price Performance

Historical Comparison
SIBN
IOVA

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: